Cargando…
Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications
Botulinum neurotoxins (BoNTs) are proteins produced by bacteria of the Clostridium family. Upon oral ingestion, BoNT causes the neuroparalytic syndrome botulism. There are seven serotypes of BoNT (serotypes A-G); BoNT-A and BoNT-B are the botulinum toxin serotypes utilized for therapeutic applicatio...
Autores principales: | Carr, Warner W., Jain, Neal, Sublett, J. Wesley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478757/ https://www.ncbi.nlm.nih.gov/pubmed/34515975 http://dx.doi.org/10.1007/s12325-021-01882-9 |
Ejemplares similares
-
Immunogenicity of botulinum toxins
por: Naumann, Markus, et al.
Publicado: (2012) -
Immunogenicity of botulinum toxin
por: Wee, Syeo Young, et al.
Publicado: (2022) -
Immunogenicity Associated with Botulinum Toxin Treatment
por: Bellows, Steven, et al.
Publicado: (2019) -
Clinical Relevance of Botulinum Toxin Immunogenicity
por: Benecke, Reiner
Publicado: (2012) -
Therapeutic Approaches of Botulinum Toxin in Gynecology
por: Moga, Marius Alexandru, et al.
Publicado: (2018)